Trehalose Alleviates the Advancement of Temporomandibular Joint Osteoarthritis via Regulating the AMPK / ULK1 Autophagy Pathway
Oral Diseases · 2025
DOI: 10.1111/odi.70122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Jingjing Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Trehalose, Autophagy, Autophagy-Related Protein-1 Homolog, AMP-Activated Protein Kinases. Die Arbeit nennt 50 Literaturangaben. Gefördert von: the Fundamental Research Funds for the Central Universities of Northwest Minzu University, the Key R&D Projects of Gansu Province, the Medical Innovation and Development Project of Lanzhou University.
Abstract (Originalsprache)
Objective
TMJOA is a chronic degenerative joint disorder with multiple etiologies that significantly impair patients' quality of life. Autophagy and apoptosis are critical to the pathogenesis of TMJOA. Trehalose is a novel autophagy activator and has significant therapeutic efficacy in mitigating diseases. This study investigated trehalose's role and possible mechanisms in TMJOA evolution, both in vitro and in vivo.
Methods
Rat condylar chondrocytes were identified by toluidine blue and type I/II collagen immunofluorescence staining. Methods such as CCK‐8 assay and immunofluorescence were used to detect the protective effect of trehalose on interleukin‐1β (IL‐1β)‐induced chondrocytes. Histological staining and other techniques were applied to evaluate its therapeutic effect on monosodium iodoacetate (MIA)‐induced TMJOA in rats and its underlying mechanism.
Results
Trehalose can suppress IL‐1β‐induced apoptosis in condylar chondrocytes by stimulating autophagy through the activation of AMP‐activated kinase (AMPK) and UNC51‐like kinase‐1 (ULK1). The inhibition of the AMPK signaling pathway negated the preventive effect of trehalose on TMJOA. TMJOA rats treated with trehalose exhibited phosphorylation of the AMPK/ULK1 pathway and activation of autophagy, accompanied by cartilage protection.
Conclusions
This study demonstrates the potential of trehalose as a novel treatment agent to impede the evolution of TMJOA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Lanzhou University, Lanzhou, China.
- Key Lab of Stomatology of State Ethnic Affairs Commission, Northwest Minzu University, Lanzhou, China.
ORCID-Profile: Jingjing Xu, Yanjiao Liu, Siqi Zhu, Wanping Yu, Hong Kang, Guangjie Bao
Förderung
- the Fundamental Research Funds for the Central Universities of Northwest Minzu University
- the Key R&D Projects of Gansu Province
- the Medical Innovation and Development Project of Lanzhou University
Zitieren
APA
Xu, J., Liu, Y., Zhu, S., Yu, W., Kang, H., & Bao, G. (2025). Trehalose Alleviates the Advancement of Temporomandibular Joint Osteoarthritis via Regulating the AMPK / ULK1 Autophagy Pathway. Oral Diseases. https://doi.org/10.1111/odi.70122
Vancouver
Xu J, Liu Y, Zhu S, Yu W, Kang H, Bao G. Trehalose Alleviates the Advancement of Temporomandibular Joint Osteoarthritis via Regulating the AMPK / ULK1 Autophagy Pathway. Oral Diseases. 2025. doi:10.1111/odi.70122
BibTeX
@article{Xu2025,
author = {Xu, Jingjing and Liu, Yanjiao and Zhu, Siqi and Yu, Wanping and Kang, Hong and Bao, Guangjie},
title = {Trehalose Alleviates the Advancement of Temporomandibular Joint Osteoarthritis via Regulating the AMPK / ULK1 Autophagy Pathway},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.70122}
}
EUVIMED